Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2014 2
2015 3
2016 3
2018 2
2019 7
2020 14
2021 13
2022 12
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Response to Letter to the Editor.
Kubo N. Kubo N. J Thorac Oncol. 2024 Mar;19(3):508. doi: 10.1016/j.jtho.2023.12.003. J Thorac Oncol. 2024. PMID: 38453329 No abstract available.
Prognosis of non-small cell lung cancer with postoperative regional lymph node recurrence.
Ohtaki Y, Nagashima T, Okano N, Kubo N, Ohtaka T, Sunaga N, Sakurai R, Miura Y, Nakazawa S, Kawatani N, Yazawa T, Yoshikawa R, Narusawa E, Shirabe K. Ohtaki Y, et al. Among authors: kubo n. Thorac Cancer. 2024 Apr;15(11):859-866. doi: 10.1111/1759-7714.15265. Epub 2024 Feb 27. Thorac Cancer. 2024. PMID: 38414316 Free PMC article.
Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon-ion radiotherapy.
Musha A, Kubo N, Kawamura H, Okano N, Sato H, Okada K, Tomizawa K, Ota N, Adachi A, Shino M, Nikkuni O, Ida S, Shirai K, Saitoh JI, Yokoo S, Chikamatsu K, Ohno T. Musha A, et al. Among authors: kubo n. Cancer Rep (Hoboken). 2023 Jul;6(7):e1825. doi: 10.1002/cnr2.1825. Epub 2023 Apr 28. Cancer Rep (Hoboken). 2023. PMID: 37115713 Free PMC article.
Carbon-ion radiotherapy for inoperable upper tract ureteral cancer.
Mizukami T, Kawamura H, Kubo N, Sato H, Kawahara M, Adachi A, Matsui H, Suzuki K, Saitoh JI, Nakano T, Ohno T. Mizukami T, et al. Among authors: kubo n. Asia Pac J Clin Oncol. 2023 Apr 23. doi: 10.1111/ajco.13960. Online ahead of print. Asia Pac J Clin Oncol. 2023. PMID: 37088970
Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG).
Okano N, Suefuji H, Nakajima M, Tokumaru S, Kubo N, Yoshida D, Suzuki O, Ishikawa H, Satouchi M, Nakayama H, Shioyama Y. Okano N, et al. Among authors: kubo n. J Radiat Res. 2023 Jun 16;64(Supplement_1):i2-i7. doi: 10.1093/jrr/rrad008. J Radiat Res. 2023. PMID: 37036751 Free PMC article.
Sustained antitumor response to lenvatinib with weekend-off and alternate-day administration in chemotherapy-refractory thymic carcinoma: a case report.
Sunaga N, Miura Y, Sakurai R, Ohshima S, Uno S, Muto S, Sato M, Tsurumaki H, Yatomi M, Koga Y, Ohtaki Y, Nagashima T, Okano N, Kubo N, Maeno T, Hisada T. Sunaga N, et al. Among authors: kubo n. Anticancer Drugs. 2023 Apr 1;34(4):605-608. doi: 10.1097/CAD.0000000000001474. Epub 2022 Dec 5. Anticancer Drugs. 2023. PMID: 36729850
66 results